Alzheimer's and Parkinson's diseases: The prion concept in relation to assembled Aβ, tau, and α-synuclein

被引:702
|
作者
Goedert, Michel [1 ]
机构
[1] MRC, Mol Biol Lab, Cambridge CB2 0QH, England
基金
英国医学研究理事会;
关键词
MULTIPLE-SYSTEM ATROPHY; GLIAL CYTOPLASMIC INCLUSIONS; GENOME-WIDE ASSOCIATION; CREUTZFELDT-JAKOB-DISEASE; TRANSGENIC MICE; NEURODEGENERATIVE-DISEASES; LEWY BODIES; EXPERIMENTAL TRANSMISSION; IDENTIFIES VARIANTS; COMMON VARIANTS;
D O I
10.1126/science.1255555
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The pathological assembly of Ab, tau, and alpha-synuclein is at the heart of Alzheimer's and Parkinson's diseases. Extracellular deposits of Ab and intraneuronal tau inclusions define Alzheimer's disease, whereas intracellular inclusions of alpha-synuclein make up the Lewy pathology of Parkinson's disease. Most cases of disease are sporadic, but some are inherited in a dominant manner. Mutations frequently occur in the genes encoding Ab, tau, and alpha-synuclein. Overexpression of these mutant proteins can give rise to disease-associated phenotypes. Protein assembly begins in specific regions of the brain during the process of Alzheimer's and Parkinson's diseases, from where it spreads to other areas.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Tau accelerates α-synuclein aggregation and spreading in Parkinson's disease
    Pan, Lina
    Li, Chunrui
    Meng, Lanxia
    Tian, Ye
    He, Mingyang
    Yuan, Xin
    Zhang, Guoxin
    Zhang, Zhaohui
    Xiong, Jing
    Chen, Guiqin
    Zhang, Zhentao
    BRAIN, 2022, 145 (10) : 3454 - 3471
  • [42] Inflammation and α-Synuclein’s Prion-like Behavior in Parkinson's Disease—Is There a Link?
    Carla M. Lema Tomé
    Trevor Tyson
    Nolwen L. Rey
    Stefan Grathwohl
    Markus Britschgi
    Patrik Brundin
    Molecular Neurobiology, 2013, 47 : 561 - 574
  • [43] α-synuclein—a link between Parkinson and Alzheimer diseases?
    Nathanial Heintz
    Huda Zoghbi
    Nature Genetics, 1997, 16 : 325 - 327
  • [44] Herpesviruses in brains in Alzheimer's and Parkinson's diseases
    Hemling, N
    Röyttä, M
    Rinne, J
    Pöllänen, P
    Broberg, E
    Tapio, V
    Vahlberg, T
    Hukkanen, V
    ANNALS OF NEUROLOGY, 2003, 54 (02) : 267 - 271
  • [45] Retinal biomarkers for Alzheimer's and Parkinson's diseases
    Bernardes, R.
    Nunes, A.
    Castelo-Branco, M.
    ACTA OPHTHALMOLOGICA, 2018, 96 : 13 - 13
  • [46] Sleep Disturbances in Alzheimer’s and Parkinson’s Diseases
    Sarah M. Rothman
    Mark P. Mattson
    NeuroMolecular Medicine, 2012, 14 : 194 - 204
  • [47] Neuropathological hallmarks of Alzheimer's and Parkinson's diseases
    Braak, H
    de Vos, RAI
    Jansen, ENH
    Bratzke, H
    Braak, E
    NEURONAL DEGENERATION AND REGENERATION: FROM BASIC MECHANISMS TO PROSPECTS FOR THERAPY, 1998, 117 : 267 - 285
  • [48] The role of amyloids in Alzheimer's and Parkinson's diseases
    Salahuddin, Parveen
    Fatima, Munazza Tamkeen
    Uversky, Vladimir N.
    Khan, Rizwan Hasan
    Islam, Zeyaul
    Furkan, Mohammad
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2021, 190 : 44 - 55
  • [49] Proposed biochemistry of Parkinson's and Alzheimer's diseases
    Robertson, D. S.
    MEDICAL HYPOTHESES, 2017, 109 : 131 - 138
  • [50] Perceptual priming in Alzheimer's and Parkinson's diseases
    Koivisto, M
    Portin, R
    Rinne, JO
    NEUROPSYCHOLOGIA, 1996, 34 (05) : 449 - 457